Litigation Details for NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)
✉ Email this page to a colleague
NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-06-05 |
| Court | District Court, District of Columbia | Date Terminated | 2023-12-04 |
| Cause | 05:702 Administrative Procedure Act | Assigned To | Randolph Daniel Moss |
| Jury Demand | None | Referred To | |
| Patents | 10,314,828; 10,335,397; 10,456,384; 6,861,053; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,023,001; 9,271,968; 9,421,195; 9,623,001; 9,629,828 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in NORWICH PHARMACEUTICALS, INC. v. BECERRA
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in NORWICH PHARMACEUTICALS, INC. v. BECERRA
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-06-05 | 1 | Exhibit 1 | (the 9'828 patent) July 24, 2029 10,314,828 (the 4'828 patent) July 24, 2029 …550 mg, is subject to periods of patent protection. The following patents and expiration dates are currently… U.S. Patent Number Expiration Date 7,045,620 (the '620 patent) June…7,612,199 (the '199 patent) June 19, 2024 7,902,206 (the '206 patent) June 19, 2024…7,906,542 (the '542 patent) June 1, 2025 7,915,275 (the '275 patent) February 23, | External link to document |
| 2023-06-12 | 12 | Exhibit Complaint | (last visited Jun. 4, 2023). 10 U.S. Patent Nos. 10,314,828; 10,335,397; 10,456,384; 7,045,620; 7,612,199… “Asserted HE Patents” refers to claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of …of U.S. Patent No. 9,421,195 (the “’195 Patent”), and claims 11-12 of U.S. Patent No. 10,335,397 (the “…claims from three asserted method of use patents (“the HE Patents”), and that Norwich’s Original ANDA should…Amended ANDA contain a Paragraph IV patent certification to any patent held to have been infringed under | External link to document |
| 2023-06-05 | 4 | Exhibit 1 to Landmon Declaration | “’195 Patent”); 9,629,828 (the “’9,828 Patent”); 10,314,828 (the “’4,828 Patent”); 10,335,397 (the “… United States Patent Nos. 7,045,620 (the “’620 Patent”); 7,612,199 (the “’199 Patent”); 7,902,206 (… (the “’206 Patent”); 7,906,542 (the “’542 Patent”); 7,915,275 (the “’275 Patent”); 8,158,644 (the “… “’644 Patent”); 8,158,781 (the “’781 Patent”); 8,193,196 (the “’196 Patent”); 8,309,569 (the “’569 …569 Patent”); 8,518,949 (the “’949 Patent”); 8,642,573 (the “’573 Patent”); 8,741,904 (the “’904 Patent | External link to document |
| 2023-08-16 | 51 | Redacted Document | (the 9'828 patent) July 24, 2029 10,314,828 (the 4'828 patent) July 24, 2029 … “Asserted HE Patents” refers to claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of …of U.S. Patent No. 9,421,195 (the “’195 Patent”), and claims 11-12 of U.S. Patent No. 10,335,397 (the “…Asserted HE Patents because, as shown below, a claim for patent infringement of the Asserted HE Patents under…of claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of U.S. Patent No. 9,421,195 (the | External link to document |
| 2023-10-09 | 61 | Exhibit Stipulation and Order in re Salix et al. v. Norwich (20-430, D. Del.) | the “’195 Patent”); 9,629,828 (the “’9,828 Patent”); 10,314,828 (the “’4,828 Patent”); 10,335,397 (the…’644 Patent; the ’781 Patent; the ’196 Patent; the ’949 Patent; the ’904 Patent; the ’017 Patent; the…452 Patent; the ’231 Patent; the ’252 Patent; the ’398 Patent; the ’968 Patent; the ’9,828 Patent; the…the ’620 patent; the ’542 Patent; the ’275 Patent; ’644 Patent; the ’781 Patent; the ’196 Patent; the ’…’949 Patent; the ’904 Patent; the ’017 Patent; the ’452 Patent; the ’231 Patent; the ’252 Patent; the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
